中国食品药品监管Issue(11)：4-9,6.DOI:10.3969/j.issn.1673-5390.2023.11.001
中国药品专利纠纷早期解决机制的建立与实践
Establishment and Practice of Early Resolution Mechanism for Drug Patent Disputes in China
摘要
Abstract
This article systematically reviews the establishment and practice of early resolution mechanisms for pharmaceutical patent disputes in China.It delves into the industry's widely concerned aspects,including the waiting period,early resolution of biological product patent disputes,and market exclusivity period,showcasing the distinctive characteristics and advantages of China's institutional design.This reflects the characteristics and unique advantages of China's institutional design.Intellectual property protection is a long-term commitment that runs through the entire lifecycle of drug production and sales.The early resolution mechanism for drug patent disputes is just one stage of intellectual property protection.Its effective and orderly operation relies on the honest participation of enterprises,emphasizing the need for collaboration among multiple departments to jointly improve intellectual property protection.关键词
药品专利纠纷早期解决机制/专利链接/知识产权保护/等待期/市场独占期Key words
early resolution mechanism for drug patent disputes/patent linkage/intellectual property protection/waiting period/market exclusivity period分类
药学引用本文复制引用
余欢,蓝恭涛,杨云云,杨胜..中国药品专利纠纷早期解决机制的建立与实践[J].中国食品药品监管,2023,(11):4-9,6.
